Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 245 articles:
HTML format



Single Articles


    August 2022
  1. NARDUCCI ML, Volpe M
    Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation.
    Eur Heart J. 2022 Aug 8. pii: 6658237. doi: 10.1093.
    PubMed    



  2. Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Aug 5. pii: 6656112. doi: 10.1093.
    PubMed    


  3. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
    PubMed    


    July 2022
  4. KHAIRY P
    Sudden cardiac death in adults with transposition of the great arteries and systemic right ventricles: preventing (night)MAREs.
    Eur Heart J. 2022;43:2695-2697.
    PubMed    


  5. BRIDA M, Chessa M, Celermajer D, Li W, et al
    Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
    Eur Heart J. 2022;43:2660-2671.
    PubMed     Abstract available



  6. Corrigendum to: Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Jul 8. pii: 6633850. doi: 10.1093.
    PubMed    


  7. LIP GYH, Lane DA, Lenarczyk R, Boriani G, et al
    Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2022;43:2442-2460.
    PubMed     Abstract available


    June 2022
  8. PROTONOTARIOS A, Bariani R, Cappelletto C, Pavlou M, et al
    Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619317. doi: 10.1093.
    PubMed     Abstract available


  9. JORDA P, Bosman LP, Gasperetti A, Mazzanti A, et al
    Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619318. doi: 10.1093.
    PubMed     Abstract available


  10. GANDJBAKHCH E, Vischer AS
    Arrhythmogenic right ventricular cardiomyopathy: the never-ending quest for a risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619319. doi: 10.1093.
    PubMed    


  11. GOYAL P, Kim M, Krishnan U, Mccullough SA, et al
    Post-operative atrial fibrillation and risk of heart failure hospitalization.
    Eur Heart J. 2022 Jun 28. pii: 6617280. doi: 10.1093.
    PubMed     Abstract available


  12. NINNI S, Longere B, Mirabel X
    Stereotactic radioablation to treat ventricular tachycardia related to a left ventricular mass.
    Eur Heart J. 2022;43:2341.
    PubMed    



  13. Erratum to: Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Jun 18. pii: 6610027. doi: 10.1093.
    PubMed    


  14. CREA F
    The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
    Eur Heart J. 2022;43:2165-2169.
    PubMed    


  15. LADOUCEUR M, Van De Bruaene A, Kauling R, Budts W, et al
    A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle.
    Eur Heart J. 2022 Jun 8. pii: 6604048. doi: 10.1093.
    PubMed     Abstract available


  16. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    PubMed    


  17. BRIGNOLE M, Soranna D, Rienstra M
    Is APAF-CRT robust enough to change clinical practice?
    Eur Heart J. 2022;43:2161-2162.
    PubMed    


  18. PABEL S, Sossalla S
    Atrial fibrillation and heart failure: novel insights into the chicken and egg dilemma.
    Eur Heart J. 2022 Jun 2. pii: 6599046. doi: 10.1093.
    PubMed    


    May 2022
  19. JOHNSEN SP, Proietti M, Maggioni AP, Lip GYH, et al
    A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.
    Eur Heart J. 2022 May 22. pii: 6590386. doi: 10.1093.
    PubMed    


  20. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    PubMed     Abstract available


  21. REMME CA, Leclercq C, Behr ER
    The European Cardiac Arrhythmia Genetics (ECGen) Focus Group.
    Eur Heart J. 2022;43:1891-1894.
    PubMed    


  22. LIUZZO G, Patrono C
    A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation.
    Eur Heart J. 2022 May 13. pii: 6585115. doi: 10.1093.
    PubMed    


  23. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    PubMed    


  24. CARRION-SANCHEZ I, Cobos-Gil MA
    Electrical alternans detected by an Apple Watch.
    Eur Heart J. 2022;43:1775.
    PubMed    


    April 2022
  25. ODENING KE, van der Linde HJ, Ackerman MJ, Volders PGA, et al
    Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond.
    Eur Heart J. 2022 Apr 21. pii: 6571781. doi: 10.1093.
    PubMed     Abstract available



  26. Corrigendum to: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569859. doi: 10.1093.
    PubMed    


  27. VAN DER MEER P, Rienstra M, van Veldhuisen DJ
    A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin?
    Eur Heart J. 2022 Apr 20. pii: 6571185. doi: 10.1093.
    PubMed    


  28. CADRIN-TOURIGNY J, Bosman LP, Nozza A, Wang W, et al
    A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569858. doi: 10.1093.
    PubMed     Abstract available


  29. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed     Abstract available


  30. STIEGLIS R, Zijlstra JA, Riedijk F, Smeekes M, et al
    Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home.
    Eur Heart J. 2022;43:1465-1474.
    PubMed     Abstract available


  31. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    PubMed    


    March 2022
  32. SANDHU A, Varosy PD
    Left atrial appendage occlusion in patients unable to tolerate anticoagulation is cost-effective in Sweden: but how generalizable is this finding?
    Eur Heart J. 2022;43:1357-1359.
    PubMed    


  33. SOLOMON SD, Claggett BL, Miao ZM, Diaz R, et al
    Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Mar 23. pii: 6552734. doi: 10.1093.
    PubMed     Abstract available


  34. CREA F
    Novel mechanistic insights into ventricular arrhythmias and sudden death.
    Eur Heart J. 2022;43:1177-1180.
    PubMed    


  35. CRIJNS HJGM, Sanders P, Albert CM, Lambiase PD, et al
    The year in cardiovascular medicine 2021: arrhythmias.
    Eur Heart J. 2022;43:1191-1197.
    PubMed    


  36. CASTILHO BM, Domingues K, Damasio AF
    Pacemaker malcapture and wide QRS complexes.
    Eur Heart J. 2022;43:1272.
    PubMed    


  37. SCHWARTZ PJ, Ackerman MJ
    Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Mar 18. pii: 6550339. doi: 10.1093.
    PubMed     Abstract available


  38. SLATER NR, Murphy KR, Sikkel MB
    VT storm in long QT resulting from COVID-19 vaccine allergy treated with epinephrine.
    Eur Heart J. 2022;43:1176.
    PubMed    


  39. MCINTYRE WF, Linz D
    Atrial fibrillation and stroke: who is low risk and what are we going to do about it?
    Eur Heart J. 2022 Mar 10. pii: 6546014. doi: 10.1093.
    PubMed    


  40. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
    Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
    Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
    PubMed     Abstract available


  41. PRINZEN FW, Auricchio A, Mullens W, Linde C, et al
    Electrical management of heart failure: from pathophysiology to treatment.
    Eur Heart J. 2022 Mar 10. pii: 6546052. doi: 10.1093.
    PubMed     Abstract available


  42. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
    Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
    Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
    PubMed     Abstract available


  43. MEHILLI J, Winhard M
    The CHADS-P2A2RC score: ready to guide the selection of treatment?
    Eur Heart J. 2022;43:1005-1007.
    PubMed    


  44. NASSER R, Meyten N, Vermeersch P, Prihadi EA, et al
    When the solution becomes the problem: left atrial appendage occlusion device-related thrombus after 5 years.
    Eur Heart J. 2022;43:1015.
    PubMed    


    February 2022
  45. KAUR H, McIntyre WF, Belley-Cote EP
    Ablate and pace for patients with atrial fibrillation: a fragile option?
    Eur Heart J. 2022 Feb 21. pii: 6533261. doi: 10.1093.
    PubMed    


  46. JARED BUNCH T, Steinberg BA
    Clinical strokes in atrial fibrillation: the tip of the iceberg.
    Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
    PubMed    


  47. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
    Silent brain infarcts impact on cognitive function in atrial fibrillation.
    Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
    PubMed     Abstract available


  48. MUTAGAYWA RK, Chin A, Karaye K, Bonny A, et al
    Unmet needs in the management of arrhythmias among heart failure patients in Africa.
    Eur Heart J. 2022 Feb 15. pii: 6528559. doi: 10.1093.
    PubMed    


  49. TAGGART P, Nash MP, Lambiase P
    Ventricular fibrillation: combined myocardial substrate and Purkinje ablation.
    Eur Heart J. 2022 Feb 9. pii: 6525334. doi: 10.1093.
    PubMed    


  50. HAISSAGUERRE M, Cheniti G, Hocini M, Sacher F, et al
    Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation.
    Eur Heart J. 2022 Feb 3. pii: 6521660. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  51. CREA F
    Cardio-oncology: a focus on cardiovascular toxicities of cancer therapies and on atrial fibrillation in cancer.
    Eur Heart J. 2022;43:245-248.
    PubMed    


  52. NARDUCCI ML, Volpe M
    Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
    Eur Heart J. 2022;43:261-262.
    PubMed    


  53. NOUBIAP JJ
    The association of atrial fibrillation with mortality in patients with breast cancer.
    Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
    PubMed    


  54. LAMBIASE PD, Theuns DA, Murgatroyd F, Barr C, et al
    Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.
    Eur Heart J. 2022 Jan 28. pii: 6516831. doi: 10.1093.
    PubMed     Abstract available


  55. GUHA A, Alonso A, Addison D
    The association of atrial fibrillation with mortality in patients with breast cancer: author reply.
    Eur Heart J. 2022 Jan 28. pii: 6516863. doi: 10.1093.
    PubMed    


  56. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    PubMed     Abstract available


  57. NICHOLLS M
    Preventing stroke in atrial fibrillation patients.
    Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
    PubMed    



  58. Corrigendum to: Incidence, Risk Factors and Mortality of Atrial Fibrillation in Breast Cancer: A SEER-Medicare Analysis.
    Eur Heart J. 2022 Jan 12. pii: 6505260. doi: 10.1093.
    PubMed    


    December 2021

  59. Erratum to: Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Eur Heart J. 2021 Dec 21. pii: 6472922. doi: 10.1093.
    PubMed    


  60. NICHOLLS M
    Making connections to overcome arrhythmias.
    Eur Heart J. 2021;42:4878-4880.
    PubMed    


  61. LABORI F, Persson J, Bonander C, Jood K, et al
    Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
    PubMed     Abstract available


  62. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Dec 8. pii: 6456446. doi: 10.1093.
    PubMed    


  63. CREA F
    Management of arrhythmias: the increasing role of artificial intelligence, genetics and cardiac resyncronization.
    Eur Heart J. 2021;42:4703-4706.
    PubMed    


  64. ATTIA ZI, Harmon DM, Behr ER, Friedman PA, et al
    Application of artificial intelligence to the electrocardiogram.
    Eur Heart J. 2021;42:4717-4730.
    PubMed     Abstract available


  65. HATALA R
    Rhythm control in asymptomatic 'early' atrial fibrillation: birth of a new paradigm?
    Eur Heart J. 2021 Dec 2. pii: 6448252. doi: 10.1093.
    PubMed    


    November 2021
  66. BOR WL, Ten Berg JM
    Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
    Eur Heart J. 2021;42:4562-4564.
    PubMed    


  67. AHLBERG G, Andreasen L, Ghouse J, Bertelsen L, et al
    Genome-wide association study identifies 18 novel loci associated with left atrial volume and function.
    Eur Heart J. 2021;42:4523-4534.
    PubMed     Abstract available


  68. CERRONE M, Marron-Linares GM, van Opbergen CJM, Costa S, et al
    Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Eur Heart J. 2021 Nov 19. pii: 6431860. doi: 10.1093.
    PubMed     Abstract available


  69. MERINO JL
    Atrial fibrillation and breast cancer: Casual or causal relationship?
    Eur Heart J. 2021 Nov 14. pii: 6427544. doi: 10.1093.
    PubMed    


  70. GUHA A, Fradley MG, Dent SF, Weintraub NL, et al
    Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.
    Eur Heart J. 2021 Nov 14. pii: 6427396. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  71. HEIDBUCHEL H, Van Gelder IC, Desteghe L
    ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project.
    Eur Heart J. 2021 Oct 25. pii: 6409895. doi: 10.1093.
    PubMed    


  72. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Oct 16. pii: 6398359. doi: 10.1093.
    PubMed    


  73. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
    Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
    Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
    PubMed     Abstract available


  74. NAGARAJAN VD, Lee SL, Robertus JL, Nienaber CA, et al
    Artificial intelligence in the diagnosis and management of arrhythmias.
    Eur Heart J. 2021;42:3904-3916.
    PubMed     Abstract available


  75. LINDE C
    Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial.
    Eur Heart J. 2021 Oct 6. pii: 6382271. doi: 10.1093.
    PubMed    


    September 2021
  76. RUSSO AM
    Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
    Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
    PubMed    


  77. WALSH R, Adler A, Amin AS, Abiusi E, et al
    Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
    Eur Heart J. 2021 Sep 24. pii: 6374783. doi: 10.1093.
    PubMed     Abstract available


  78. TINKER A
    Does knowledge of the mutation in hereditary long QT syndrome aid risk stratification?
    Eur Heart J. 2021 Sep 20. pii: 6372801. doi: 10.1093.
    PubMed    


  79. CREA F
    The ESC Guidelines on cardiac pacing and resynchronization, and the many facets of atrial fibrillation.
    Eur Heart J. 2021;42:3411-3414.
    PubMed    


  80. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrill
    Eur Heart J. 2021 Sep 14. pii: 6370283. doi: 10.1093.
    PubMed    


  81. GLIKSON M, Nielsen JC, Kronborg MB, Michowitz Y, et al
    2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
    Eur Heart J. 2021;42:3427-3520.
    PubMed    


  82. LIN YN, Mesquita T, Sanchez L, Chen YH, et al
    Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice.
    Eur Heart J. 2021;42:3558-3571.
    PubMed     Abstract available


  83. SCHWARTZ PJ, Tan HL
    Long QT syndrome, artificial intelligence, and common sense.
    Eur Heart J. 2021 Sep 11. pii: 6368899. doi: 10.1093.
    PubMed    


  84. SCHWARTZ PJ, Moreno C, Kotta MC, Pedrazzini M, et al
    Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.
    Eur Heart J. 2021 Sep 10. pii: 6368299. doi: 10.1093.
    PubMed     Abstract available


  85. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
    PubMed     Abstract available


  86. STEINBERG C, Krahn AD
    Quinidine vs. ICD therapy in short-coupled ventricular fibrillation-is a randomized trial the next logical step?
    Eur Heart J. 2021 Sep 4. pii: 6364089. doi: 10.1093.
    PubMed    


  87. BELHASSEN B
    Quinidine vs. ICD in patients with short-coupled idiopathic ventricular fibrillation: a call for a multicenter randomized trial.
    Eur Heart J. 2021 Sep 4. pii: 6364083. doi: 10.1093.
    PubMed    


  88. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    PubMed     Abstract available


  89. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
    Day-to-day measurement of physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
    PubMed     Abstract available


  90. PRIFTI E, Fall A, Davogustto G, Pulini A, et al
    Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome.
    Eur Heart J. 2021 Sep 1. pii: 6361017. doi: 10.1093.
    PubMed     Abstract available


  91. ELLIOTT AD, Middeldorp ME, Linz DK
    The ins and outs of physical activity monitoring: implications for atrial fibrillation management.
    Eur Heart J. 2021 Sep 1. pii: 6361015. doi: 10.1093.
    PubMed    


    August 2021
  92. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Aug 28. pii: 6358077. doi: 10.1093.
    PubMed     Abstract available


  93. CURTAIN JP, Docherty KF, Jhund PS, Petrie MC, et al
    Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
    Eur Heart J. 2021 Aug 27. pii: 6358075. doi: 10.1093.
    PubMed     Abstract available


  94. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
    Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
    PubMed     Abstract available


  95. LIGHT PE
    Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure.
    Eur Heart J. 2021 Aug 27. pii: 6358226. doi: 10.1093.
    PubMed    


  96. CHIANG PH, Hsu YC, Wei JC
    Methodological considerations when discussing the fracture risk of atrial fibrillation patients taking different drug.
    Eur Heart J. 2021 Aug 11. pii: 6348063. doi: 10.1093.
    PubMed    


  97. HUANG HK, Tu YK, Loh CH
    Fracture risk associated with different oral anticoagulants in patients with atrial fibrillation: updated evidence from real-world observational studies and clinical trials.
    Eur Heart J. 2021 Aug 11. pii: 6348060. doi: 10.1093.
    PubMed    


  98. WANG N, Sun Y, Zhang H, Wang B, et al
    Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.
    Eur Heart J. 2021 Aug 10. pii: 6347324. doi: 10.1093.
    PubMed     Abstract available


  99. SALEM JE, Nguyen LS, Moslehi JJ, Ederhy S, et al
    Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
    Eur Heart J. 2021 Aug 9. pii: 6346756. doi: 10.1093.
    PubMed     Abstract available


  100. NICHOLLS M
    Reflections on EHRA 2021.
    Eur Heart J. 2021;42:2880-2881.
    PubMed    


  101. RASMUSSEN PV, Hylek E
    Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants.
    Eur Heart J. 2021 Aug 4. pii: 6339772. doi: 10.1093.
    PubMed    


  102. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
    Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
    PubMed     Abstract available


  103. REIFFEL JA
    When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
    Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
    PubMed    


    July 2021
  104. WILDE AAM, Wu CI
    Does function trump bioinformatics in Brugada syndrome-associated SCN5A mutation calling? Patients, computers, and patches.
    Eur Heart J. 2021;42:2864-2865.
    PubMed    


  105. ISHIKAWA T, Kimoto H, Mishima H, Yamagata K, et al
    Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Eur Heart J. 2021;42:2854-2863.
    PubMed     Abstract available


  106. ALHUMAID W, Yogasundaram H, Senaratne JM
    Slow bidirectional ventricular tachycardia as a manifestation of immune checkpoint inhibitor myocarditis.
    Eur Heart J. 2021;42:2868.
    PubMed    


  107. GUASCH E, Nattel S
    Ageing, comorbidities, and the complex determinants of atrial fibrillation in athletes.
    Eur Heart J. 2021 Jul 23. pii: 6327053. doi: 10.1093.
    PubMed    


  108. ADABAG S, Madjid M, Cheng A
    An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic.
    Eur Heart J. 2021 Jul 19. pii: 6323687. doi: 10.1093.
    PubMed    



  109. Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.
    Eur Heart J. 2021 Jul 16. pii: 6322394. doi: 10.1093.
    PubMed    


  110. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    PubMed     Abstract available


  111. BUNTING KV, Stanbury M, Tica O, Kotecha D, et al
    Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial.
    Eur Heart J. 2021;42:2411-2414.
    PubMed    


    June 2021

  112. Erratum to: Alcohol Consumption, Cardiac Biomarkers and Risk of Atrial Fibrillation and Adverse Outcomes.
    Eur Heart J. 2021 Jun 30. pii: 6311430. doi: 10.1093.
    PubMed    


  113. VAN DER REE MH, Postema PG
    What's in a name? further classification of patients with apparent idiopathic ventricular fibrillation.
    Eur Heart J. 2021 Jun 21. pii: 6306957. doi: 10.1093.
    PubMed    


  114. SCHNABEL RB, Fabritz L, Kirchhof P
    Mobile health for walking on the tightrope of optimal physical activity to reduce the risk of atrial fibrillation.
    Eur Heart J. 2021 Jun 20. pii: 6306826. doi: 10.1093.
    PubMed    



  115. Corrigendum to: A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
    Eur Heart J. 2021 Jun 16. pii: 6300115. doi: 10.1093.
    PubMed    


  116. VERSTRAELEN TE, van Lint FHM, Bosman LP, de Brouwer R, et al
    Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
    Eur Heart J. 2021 Jun 11. pii: 6296140. doi: 10.1093.
    PubMed     Abstract available


  117. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  118. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    PubMed     Abstract available


  119. PARK S, Lee S, Kim Y, Lee Y, et al
    Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
    Eur Heart J. 2021 May 23. pii: 6282432. doi: 10.1093.
    PubMed     Abstract available


  120. BENN M
    Atrial Fibrillation And Chronic Kidney Disease.
    Eur Heart J. 2021 May 23. pii: 6282434. doi: 10.1093.
    PubMed    


  121. TOMSITS P, Clauss S, Kaab S
    Genetic insight into sick sinus syndrome. Is there a pill for it or how far are we on the translational road to personalized medicine?
    Eur Heart J. 2021;42:1972-1975.
    PubMed    


  122. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    PubMed     Abstract available


  123. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
    Genetic insight into sick sinus syndrome.
    Eur Heart J. 2021;42:1959-1971.
    PubMed     Abstract available


  124. STEINBERG C, Davies B, Mellor G, Tadros R, et al
    Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
    Eur Heart J. 2021 May 19. pii: 6278425. doi: 10.1093.
    PubMed     Abstract available


  125. CSENGERI D, Sprunker NA, Schnabel RB
    Alcohol and atrial fibrillation: dose matters, not so much the type.
    Eur Heart J. 2021 May 9. pii: 6272848. doi: 10.1093.
    PubMed    


  126. MESSERLI FH, Dobner S
    Alcohol and atrial fibrillation: not all drinks are created equal.
    Eur Heart J. 2021 May 8. pii: 6272093. doi: 10.1093.
    PubMed    


  127. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    PubMed    


  128. GNECCHI M, Sala L, Schwartz PJ
    Precision Medicine and cardiac channelopathies: when dreams meet reality.
    Eur Heart J. 2021;42:1661-1675.
    PubMed     Abstract available


  129. DELISE P
    Risk stratification in Brugada syndrome: the challenge of the grey zone.
    Eur Heart J. 2021;42:1696-1697.
    PubMed    


  130. PROBST V, Goronflot T, Anys S, Tixier R, et al
    Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome.
    Eur Heart J. 2021;42:1687-1695.
    PubMed     Abstract available


  131. MINOIS D, Sellal JM, Magnin I, de Chillou C, et al
    Left ventricular diverticulum associated with two concealed atrioventricular accessory pathways.
    Eur Heart J. 2021;42:1714.
    PubMed    


    April 2021
  132. GALIUTO L, Volpe M
    Cryoblation as first-line treatment of new-onset atrial fibrillation?
    Eur Heart J. 2021;42:1543-1544.
    PubMed    


  133. SMOLDEREN KG, Burg MM
    A broken heart after child loss.
    Eur Heart J. 2021;42:1496-1498.
    PubMed    


  134. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    PubMed    


    March 2021

  135. Corrigendum to: Long-term outcomes in young patients with atrioventricular block of unknown aetiology.
    Eur Heart J. 2021 Mar 31. pii: 6205935. doi: 10.1093.
    PubMed    


  136. EL-BATTRAWY I, Lang S, Zhou X, Akin I, et al
    Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
    Eur Heart J. 2021;42:1270-1272.
    PubMed    


  137. PAPPONE C, Ciconte G, Micaglio E, Monasky MM, et al
    Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
    Eur Heart J. 2021;42:1273-1274.
    PubMed    


  138. DE JONG Y, Fu EL, van Diepen M, Trevisan M, et al
    Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function.
    Eur Heart J. 2021 Mar 26. pii: 6188994. doi: 10.1093.
    PubMed     Abstract available


  139. OYAMA K, Giugliano RP, Berg DD, Ruff CT, et al
    Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2021 Mar 24. pii: 6184829. doi: 10.1093.
    PubMed     Abstract available


  140. CAUTI FM, Rossi P, Sommer P
    The sympathetic nervous system and ventricular arrhythmias: an inseparable union.
    Eur Heart J. 2021 Mar 23. pii: 6181767. doi: 10.1093.
    PubMed    


  141. YOUNIS A, Goldenberg I
    Extending the MADIT-ICD benefit score to heterogenous heart failure populations.
    Eur Heart J. 2021 Mar 18. pii: 6177051. doi: 10.1093.
    PubMed    


  142. POSTEMA PG, Walsh R, Bezzina CR
    Illuminating the path from genetics to clinical outcome in Brugada syndrome.
    Eur Heart J. 2021;42:1091-1093.
    PubMed    


  143. BEHR ER, Ben-Haim Y, Ackerman MJ, Krahn AD, et al
    Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
    Eur Heart J. 2021;42:1073-1081.
    PubMed     Abstract available


  144. CICONTE G, Monasky MM, Santinelli V, Micaglio E, et al
    Brugada syndrome genetics is associated with phenotype severity.
    Eur Heart J. 2021;42:1082-1090.
    PubMed     Abstract available


  145. ROSSO R, Hochstadt A, Viskin D, Chorin E, et al
    Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis.
    Eur Heart J. 2021 Mar 10. pii: 6166275. doi: 10.1093.
    PubMed     Abstract available


  146. MARTINS RP, Baruteau AE, Daubert JC
    Poor prognosis in young patients with atrioventricular block of unknown aetiology: who is to blame? The physician or the pacemaker?
    Eur Heart J. 2021 Mar 8. pii: 6162692. doi: 10.1093.
    PubMed    


  147. IRIART X, Metras A, Coiffic A, Thambo JB, et al
    Late device-related thrombus after left atrial appendage closure: never let your guard down.
    Eur Heart J. 2021;42:1050.
    PubMed    


    February 2021
  148. ENGLER D, Heidbuchel H, Schnabel RB
    Digital, risk-based screening for atrial fibrillation in the European community-the AFFECT-EU project funded by the European Union.
    Eur Heart J. 2021 Feb 20. pii: 6145319. doi: 10.1093.
    PubMed    


  149. DIDERIKSEN JR, Christiansen MK, Johansen JB, Nielsen JC, et al
    Long-term outcomes in young patients with atrioventricular block of unknown aetiology.
    Eur Heart J. 2021 Feb 18. pii: 6143533. doi: 10.1093.
    PubMed     Abstract available


  150. SAWANO S, Nakayama A, Morita H, Komuro I, et al
    Rathke's cleft cyst induced cardiac arrest.
    Eur Heart J. 2021;42:714.
    PubMed    



  151. Corrigendum to: Predicted Benefit of an Implantable Cardioverter-Defibrillator: The MADIT-ICD Benefit Score.
    Eur Heart J. 2021 Feb 7. pii: 6130061. doi: 10.1093.
    PubMed    


  152. CREA F
    Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic.
    Eur Heart J. 2021;42:361-364.
    PubMed    


  153. BORIANI G, Vitolo M
    COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease.
    Eur Heart J. 2021;42:529-532.
    PubMed    


  154. CRIJNS HJGM, Prinzen F, Lambiase PD, Sanders P, et al
    The year in cardiovascular medicine 2020: arrhythmias.
    Eur Heart J. 2021;42:499-507.
    PubMed     Abstract available


  155. SCHNEEWEIS C, Ahrens I, Saygili E, Steven D, et al
    Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation.
    Eur Heart J. 2021;42:544.
    PubMed    


    January 2021
  156. WEI D, Olofsson T, Chen H, Janszky I, et al
    Death of a child and the risk of atrial fibrillation: a nationwide cohort study in Sweden.
    Eur Heart J. 2021 Jan 30. pii: 6124028. doi: 10.1093/eurheartj/ehaa1084.
    PubMed     Abstract available


  157. SULZGRUBER P, Doehner W, Niessner A
    Valvular atrial fibrillation and a CHA2DS2-VASc score of 1-a statement of the ESC working group on cardiovascular pharmacotherapy and ESC council on stroke.
    Eur Heart J. 2021 Jan 26. pii: 6120259. doi: 10.1093/eurheartj/ehaa1081.
    PubMed    


  158. AL-KHAYATT BM, Salciccioli JD, Marshall DC, Krahn AD, et al
    Paradoxical impact of socioeconomic factors on outcome of atrial fibrillation in Europe: trends in incidence and mortality from atrial fibrillation.
    Eur Heart J. 2021 Jan 25. pii: 6120042. doi: 10.1093/eurheartj/ehaa1077.
    PubMed     Abstract available


  159. RIENSTRA M, Van Gelder IC
    Incidence and outcome of atrial fibrillation: diversity throughout Europe.
    Eur Heart J. 2021 Jan 25. pii: 6120041. doi: 10.1093/eurheartj/ehaa1078.
    PubMed    


  160. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    PubMed    


  161. CSENGERI D, Sprunker NA, Di Castelnuovo A, Niiranen T, et al
    Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes.
    Eur Heart J. 2021 Jan 13. pii: 6090248. doi: 10.1093.
    PubMed     Abstract available


  162. WONG JA, Conen D
    Alcohol consumption, atrial fibrillation, and cardiovascular disease: finding the right balance.
    Eur Heart J. 2021 Jan 13. pii: 6090247. doi: 10.1093.
    PubMed    


  163. YOUNIS A, Goldberger JJ, Kutyifa V, Zareba W, et al
    Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.
    Eur Heart J. 2021 Jan 8. pii: 6071721. doi: 10.1093/eurheartj/ehaa1057.
    PubMed     Abstract available


  164. GALIUTO L, Patrono C
    Rivaroxaban, a novel option for patients with atrial fibrillation and a bioprosthetic mitral valve.
    Eur Heart J. 2021 Jan 4. pii: 6062729. doi: 10.1093/eurheartj/ehaa1075.
    PubMed    


  165. ORAII A, Bozorgi A, Tajdini M
    Differences in the 2020 ESC versus 2019 ACC/AHA/HRS guidelines on atrial fibrillation.
    Eur Heart J. 2021 Jan 4. pii: 6062049. doi: 10.1093/eurheartj/ehaa1098.
    PubMed    


  166. HAMILTON GW, Lim HS
    Ventricular tachycardia vs. supraventricular tachycardia with aberrancy.
    Eur Heart J. 2021;42:133.
    PubMed    


    December 2020
  167. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    PubMed     Abstract available


  168. BARRA S, Narayanan K, Garcia R, Marijon E, et al
    Time to revisit implantable cardioverter-defibrillator implantation criteria in women.
    Eur Heart J. 2020 Dec 23. pii: 6046140. doi: 10.1093.
    PubMed    


  169. TAMURA S, Shimeno K, Abe Y, Naruko T, et al
    A right-to-left atrial shunt via an iatrogenic atrial septal defect after atrial fibrillation ablation induced by a percutaneous left ventricular assist device.
    Eur Heart J. 2020 Dec 16. pii: 6035373. doi: 10.1093/eurheartj/ehaa1027.
    PubMed    


  170. O'SHEA CJ, Thomas G, Middeldorp ME, Harper C, et al
    Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic.
    Eur Heart J. 2020 Dec 16. pii: 6035202. doi: 10.1093.
    PubMed     Abstract available


  171. WILDE AAM, Lodder EM
    Biomarkers in inherited arrhythmias: necessity for validation and collaboration.
    Eur Heart J. 2020;41:4523-4524.
    PubMed    


  172. HAMILTON RM, Chatterjee D, Saguner AM
    Biomarkers in inherited arrhythmias: opportunities for validation and collaboration.
    Eur Heart J. 2020;41:4521-4522.
    PubMed    


  173. PASCALE P, Haddad C
    Uninterrupted vs. interrupted non-vitamin K antagonist oral anticoagulant during atrial fibrillation catheter ablation: expert opinion or true evidence?
    Eur Heart J. 2020 Dec 9. pii: 6028512. doi: 10.1093/eurheartj/ehaa1000.
    PubMed    


  174. MARTINI B
    Six young patients resuscitated from ventricular fibrillation between 1980 and 1989.
    Eur Heart J. 2020;41:4384-4387.
    PubMed    


    November 2020

  175. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Nov 26. pii: 6006712. doi: 10.1093.
    PubMed    


  176. FAZZARI F
    A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
    Eur Heart J. 2020 Nov 25. pii: 6006471. doi: 10.1093.
    PubMed    


  177. SIMONS SO, Elliott A, Sastry M, Hendriks JM, et al
    Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective.
    Eur Heart J. 2020 Nov 18. pii: 5989803. doi: 10.1093.
    PubMed     Abstract available


  178. ARSENOS P, Antoniou CK, Gatzoulis KA
    Risk stratification refinement and implantable cardioverter defibrillator protection for the coronary artery disease patients with a preserved left ventricular systolic function with a two-step programmed ventricular stimulation-inclusive approach.
    Eur Heart J. 2020 Nov 16. pii: 5983737. doi: 10.1093.
    PubMed    


  179. VERHAMME P, Budts W, Van de Werf F
    Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?
    Eur Heart J. 2020;41:4178-4180.
    PubMed    


  180. COLLET JP, Thiele H
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 13. pii: 5981490. doi: 10.1093.
    PubMed    


  181. CAMM AJ
    Does ablation of atrial fibrillation reduce the likelihood of dementia? A step closer but not yet there.
    Eur Heart J. 2020 Nov 11. pii: 5974605. doi: 10.1093.
    PubMed    


  182. MILLENAAR D, Bohm M
    Atrial fibrillation: selecting patients at risk for cardiovascular events by blood pressure.
    Eur Heart J. 2020 Nov 9. pii: 5964151. doi: 10.1093.
    PubMed    


  183. VERDECCHIA P, Angeli F, Cavallini C
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.
    PubMed    


  184. BARRIOS V, Escobar C
    Atrial fibrillation, an equivalent of cardiovascular disease risk.
    Eur Heart J. 2020 Nov 9. pii: 5964152. doi: 10.1093.
    PubMed    


  185. MEIER S, Yu C, Raju H, Naoum C, et al
    Incidental diagnosis of arrhythmogenic right ventricular cardiomyopathy on coronary computed tomography angiography in a septuagenarian.
    Eur Heart J. 2020 Nov 9. pii: 5964155. doi: 10.1093.
    PubMed    


  186. IRIGARAY SIERRA P, Gayan Ordas J, Pastor Pueyo P, Viles Bertran D, et al
    Abdominal pain and atrioventricular block: beyond pacemaker implantation.
    Eur Heart J. 2020 Nov 9. pii: 5964171. doi: 10.1093.
    PubMed    


  187. NANJO A, Evans H, Direk K, Hayward AC, et al
    Prevalence, incidence, and outcomes across cardiovascular diseases in homeless individuals using national linked electronic health records.
    Eur Heart J. 2020;41:4011-4020.
    PubMed     Abstract available


    October 2020
  188. SAMA IE, Voors AA, van Veldhuisen DJ
    New data on soluble ACE2 in patients with atrial fibrillation reveal potential value for treatment of patients with COVID-19 and cardiovascular disease.
    Eur Heart J. 2020 Oct 29. pii: 5942721. doi: 10.1093.
    PubMed    


  189. FANAROFF AC, Lopes RD
    Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapy.
    Eur Heart J. 2020 Oct 25. pii: 5939783. doi: 10.1093.
    PubMed    


  190. GALIUTO L, Patrono C
    Early rhythm control for early atrial fibrillation? Comment on the EAST-AFNET 4 Trial.
    Eur Heart J. 2020 Oct 25. pii: 5939827. doi: 10.1093.
    PubMed    


  191. BOERSMA LVA
    Surgical or catheter ablation for longstanding persistent atrial fibrillation: a game of rock paper scissors?
    Eur Heart J. 2020 Oct 17. pii: 5929304. doi: 10.1093.
    PubMed    


  192. LIUZZO G, Patrono C
    Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.
    Eur Heart J. 2020 Oct 17. pii: 5927543. doi: 10.1093.
    PubMed    


  193. SCHWARTZ PJ
    1970-2020: 50 years of research on the long QT syndrome-from almost zero knowledge to precision medicine.
    Eur Heart J. 2020 Oct 15. pii: 5923771. doi: 10.1093.
    PubMed     Abstract available



  194. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Oct 8. pii: 5919233. doi: 10.1093.
    PubMed    


  195. KIM D, Yang PS, Sung JH, Jang E, et al
    Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2020 Oct 6. pii: 5918337. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  196. DISERTORI M, Mase M, Nollo G
    Is the clinical benefit of primary prevention implantable cardioverter-defibrillator overestimated? The role of sudden cardiac death to total mortality ratio.
    Eur Heart J. 2020 Sep 30. pii: 5913137. doi: 10.1093.
    PubMed    


  197. WALLENTIN L, Lindback J, Eriksson N, Hijazi Z, et al
    Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
    Eur Heart J. 2020 Sep 27. pii: 5912214. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  198. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Aug 29. pii: 5899003. doi: 10.1093.
    PubMed    


  199. HALDAR S, Khan HR, Boyalla V, Kralj-Hans I, et al
    Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial.
    Eur Heart J. 2020 Aug 29. pii: 5898905. doi: 10.1093.
    PubMed     Abstract available


  200. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    PubMed     Abstract available


  201. MARONA M, Celinska-Spodar M, Spiewak M, Konopka A, et al
    Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.
    Eur Heart J. 2020;41:2921.
    PubMed    


  202. LUSCHER TF
    Optimizing management of atrial fibrillation: integrated care, blood pressure control, ablation, and left atrial appendix occlusion.
    Eur Heart J. 2020;41:2821-2825.
    PubMed    


  203. WILDE AAM, Lodder EM
    A highly specific biomarker for Brugada syndrome. Also too good to be true?
    Eur Heart J. 2020;41:2891-2893.
    PubMed    


  204. HOLMES DR, Alkhouli M
    Rebellious palpitations.
    Eur Heart J. 2020;41:2902-2903.
    PubMed    


  205. BLASZYK K, Gwizdala A
    Narrow or broad QRS tachycardia: does 120 ms matter?
    Eur Heart J. 2020;41:2908.
    PubMed    


  206. FUKUMA T, Fujimoto N, Ishiyama M, Dohi K, et al
    Atrial wall thickening, fevers, and atrial fibrillation caused by immunoglobulin G4-related biatrial cardiomyopathy.
    Eur Heart J. 2020 Aug 3. pii: 5879863. doi: 10.1093.
    PubMed    


    July 2020
  207. INCIARDI RM, Adamo M, Lupi L, Metra M, et al
    Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?
    Eur Heart J. 2020 Jul 22. pii: 5875228. doi: 10.1093.
    PubMed    


  208. SANCHIS-GOMAR F, Perez-Quilis C, Lavie CJ
    Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?
    Eur Heart J. 2020 Jul 20. pii: 5874071. doi: 10.1093.
    PubMed    


  209. BLOMSTROM-LUNDQVIST C
    Effects of COVID-19 lockdown strategies on management of atrial fibrillation.
    Eur Heart J. 2020 Jul 2. pii: 5866605. doi: 10.1093.
    PubMed    


    June 2020
  210. HOLT A, Gislason GH, Schou M, Zareini B, et al
    New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people.
    Eur Heart J. 2020 Jun 24. pii: 5861973. doi: 10.1093.
    PubMed     Abstract available


  211. DUSI V, De Ferrari GM, Schwartz PJ
    There are 100 ways by which the sympathetic nervous system can trigger life-threatening arrhythmias.
    Eur Heart J. 2020;41:2180-2182.
    PubMed    


  212. AZARKISH M, Laleh Far V, Eslami M, Mollazadeh R, et al
    Transient complete heart block in a patient with critical COVID-19.
    Eur Heart J. 2020;41:2131.
    PubMed    


  213. LINZ D, Pluymaekers NAHA, Hendriks JM
    TeleCheck-AF for COVID-19.
    Eur Heart J. 2020;41:1954-1955.
    PubMed    


    May 2020
  214. SHANTSILA A, Shantsila E, Lip GYH
    Blood pressure targets in atrial fibrillation.
    Eur Heart J. 2020 May 27. pii: 5847949. doi: 10.1093.
    PubMed    


  215. MARK ESTES NA, Saba S
    Primary prevention of sudden death with the implantable cardioverter defibrillator: bridging the evidence gap.
    Eur Heart J. 2020 May 19. pii: 5840425. doi: 10.1093.
    PubMed    


  216. INCIARDI RM, Adamo M, Lupi L, Cani DS, et al
    Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.
    Eur Heart J. 2020;41:1821-1829.
    PubMed     Abstract available


  217. SUGIYAMA T
    Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants.
    Eur Heart J. 2020 May 7. pii: 5831946. doi: 10.1093.
    PubMed    


  218. HUANG HK, Yeh JI, Loh CH
    Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants: a meta-analysis based on current observational studies.
    Eur Heart J. 2020 May 7. pii: 5831944. doi: 10.1093.
    PubMed    


  219. ZABEL M, Willems R, Lubinski A, Bauer A, et al
    Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.
    Eur Heart J. 2020 May 6. pii: 5830833. doi: 10.1093.
    PubMed     Abstract available


  220. GUO Y, Lane DA, Chen Y, Lip GYH, et al
    Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation.
    Eur Heart J. 2020;41:1617-1619.
    PubMed    


  221. GARGIULO G, Goette A, Vranckx P, Valgimigli M, et al
    Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help.
    Eur Heart J. 2020;41:1701-1702.
    PubMed    


    April 2020
  222. DURU F, Brunckhorst C
    Recipient of the 2019 Zurich Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Research Prize in Basic Science.
    Eur Heart J. 2020;41:1538.
    PubMed    


  223. MAURY P, Rollin A, Voglimacci-Stephanopoli Q, Delmas C, et al
    Termination of sustained ventricular fibrillation by catheter ablation.
    Eur Heart J. 2020 Apr 15. pii: 5820564. doi: 10.1093.
    PubMed    


  224. SACHECK JM, Mozaffarian D
    Physical activity in patients with existing atrial fibrillation: time for exercise prescription?
    Eur Heart J. 2020;41:1476-1478.
    PubMed    


  225. LINDE C
    Integrated care for atrial fibrillation: time for widespread use.
    Eur Heart J. 2020 Apr 13. pii: 5819644. doi: 10.1093.
    PubMed    


  226. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
    Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
    Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  227. KUWABARA M, Borghi C, Johnson RJ
    Febuxostat and atrial fibrillation.
    Eur Heart J. 2020 Mar 30. pii: 5813683. doi: 10.1093.
    PubMed    


  228. LUSCHER TF
    Challenges in atrial fibrillation: detection, alert systems, fibrosis, and infection.
    Eur Heart J. 2020;41:1063-1066.
    PubMed    


  229. DE CATERINA R, Mundi S, Fusaro M
    Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs.
    Eur Heart J. 2020;41:1109-1111.
    PubMed    


  230. STEINBERG BA, Piccini JP
    Call me maybe? The right time and place for BPAs in EHRs.
    Eur Heart J. 2020;41:1097-1099.
    PubMed    


    February 2020
  231. AGASTHI P, Tseng A, Mulpuru SK
    Appropriate cohort selection and its impact on a meta-analysis evaluating the efficacy of direct oral anticoagulants post-percutaneous coronary intervention.
    Eur Heart J. 2020 Feb 14. pii: 5736264. doi: 10.1093.
    PubMed    


  232. SCHMIDT AS, Lauridsen KG, Lofgren B
    Maximizing cardioversion efficacy: maximum-fixed energy shocks and what else?
    Eur Heart J. 2020;41:722.
    PubMed    


  233. EZEKOWITZ JA
    All for one, but not one for all.
    Eur Heart J. 2020;41:642-644.
    PubMed    


    January 2020
  234. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
    Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
    Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  235. LANCINI D, Shetty R
    Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
    Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
    PubMed    


  236. KALLA M, Hao G, Tapoulal N, Tomek J, et al
    The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  237. CHATHA SR, Westwood M, Moon JC, Captur G, et al
    New-onset heart failure: free-breathing motion-corrected late gadolinium enhancement rescues the endomyocardial fibrosis diagnosis.
    Eur Heart J. 2019 Sep 27. pii: 5575240. doi: 10.1093.
    PubMed    


    August 2019
  238. BJURSTEN H, Rasmussen M, Nozohoor S, Gotberg M, et al
    Infective endocarditis after transcatheter aortic valve implantation: a nationwide study.
    Eur Heart J. 2019 Aug 21. pii: 5552575. doi: 10.1093.
    PubMed     Abstract available


  239. PACKER M
    What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
    Eur Heart J. 2019 Aug 7. pii: 5544750. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  240. REDDY YNV, Borlaug BA, O'Connor CM, Gersh BJ, et al
    Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.
    Eur Heart J. 2019 Jun 14. pii: 5519089. doi: 10.1093.
    PubMed     Abstract available


  241. THALMANN G, Schneiter S, Kawel-Boehm N, Mayer KA, et al
    An unusual intracardiac thrombus in an 81-year-old man with severe symptomatic aortic stenosis.
    Eur Heart J. 2019 Jun 4. pii: 5510781. doi: 10.1093.
    PubMed    


    May 2019
  242. URENA M, Rodes-Cabau J
    New-onset conduction disturbances: the last obstacle in the way of transcatheter aortic valve implantation.
    Eur Heart J. 2019 May 9. pii: 5487604. doi: 10.1093.
    PubMed    


  243. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
    Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  244. OBOKATA M, Reddy YNV, Melenovsky V, Pislaru S, et al
    Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.
    Eur Heart J. 2018 Dec 12. pii: 5240922. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  245. BERGMARK BA, Faxon DP
    Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome?
    Eur Heart J. 2018 Nov 15. pii: 5184544. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: